Tuhura biosciences, inc.HURA.US Overview

US StockHealthcare

(No presentation for HURA)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

HURA Overall Performance

HURA AI Analysis & Strategy

HURA Recent Performance

2.21%

Tuhura biosciences, inc.

0.81%

Avg of Sector

-1.14%

S&P500

HURA PowerScanner

HURA Key Information

HURA Valuation Metrics

HURA Earnings Table

HURA Profile

TuHURA Biosciences, Inc. is a phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company is headquartered in Tampa, FL.